Search - tctmd.com

Displaying 581 - 600 of 691

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

Jason Kahn

July 05, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

May 03, 2013

News Daily News

Mortality Varies by Revascularization Method in Dialysis Patients

Caitlin E. Cox

April 19, 2013

News Daily News

La Mortalidad Varía según el Método de Revacularización en Pacientes a Diálisis

Caitlin E. Cox

April 19, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

Presentation

Long-term Survival and Repeat Revascularization in Dialysis Patients Following CABG and PCI with DES and BMS in the United States

Presenter: G.R. Shroff

April 12, 2013

News Daily News

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Jason Kahn

March 25, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

Presentation TCT 2013

Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted indirect comparison meta-analysis of randomized trials

Presenter: Salvatore Cassese, Robert Byrne, Ilka Ott, Tareq Ibrahim, Tomohisa Tada, Lamin King, Adnan Kastrati, Massimiliano Fusaro

January 31, 2013

Presentation TCT 2013

A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

Presenter: Jean Fajadet, Eulogio Garcia, David Hildick-Smith, Sonia Petronio, Sigmund Silber, Franz-Josef Neumann, Azfar Zaman, Jochen W?hrle, Mark Spence, simon elhadad

January 31, 2013

News Daily News

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

Jason Kahn

January 24, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

News Conference News AHA 2012

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Jason Kahn

November 04, 2012

Presentation TCT 2012

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Presenter: A. Pieter Kappetein

October 23, 2012

Presentation TCT 2012

Complete vs. Incomplete Revascularization: Impact on Outcomes and Implications for Strategy

Presenter: Giora Weisz

October 22, 2012

Advertisement

Drug-Eluting Balloons Lower TLR in Diabetics with Critical Limb Ischemia

TWENTE: Still Few Differences between ZES and EES at 2 Years

Meta-analysis: DES Beneficial But May Not Save Limbs, Improve Survival in PAD Patients

Mortality Varies by Revascularization Method in Dialysis Patients

La Mortalidad Varía según el Método de Revacularización en Pacientes a Diálisis

Colchicine Reduces BMS Restenosis in Diabetic Patients

Long-term Survival and Repeat Revascularization in Dialysis Patients Following CABG and PCI with DES and BMS in the United States

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Pair of Studies Show Positive Stent Results at ACC

Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted indirect comparison meta-analysis of randomized trials

A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

EES Outperform First-Generation DES in Treatment of CTOs

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

TCT-43. Final Five-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease

Complete vs. Incomplete Revascularization: Impact on Outcomes and Implications for Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content